These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 6681730

  • 1. Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection.
    Howell SB, Pfeifle CE, Wung WE, Olshen RA.
    Cancer Res; 1983 Mar; 43(3):1426-31. PubMed ID: 6681730
    [Abstract] [Full Text] [Related]

  • 2. Phase I/pharmacokinetic study of intraperitoneal cisplatin and etoposide.
    Zimm S, Cleary SM, Lucas WE, Weiss RJ, Markman M, Andrews PA, Schiefer MA, Kim S, Horton C, Howell SB.
    Cancer Res; 1987 Mar 15; 47(6):1712-6. PubMed ID: 3815369
    [Abstract] [Full Text] [Related]

  • 3. Intraperitoneal high-dose cisplatin and etoposide with systemic thiosulfate protection in second-line treatment of advanced ovarian cancer.
    Malmström H, Rasmussen S, Simonsen E.
    Gynecol Oncol; 1993 May 15; 49(2):166-71. PubMed ID: 8504983
    [Abstract] [Full Text] [Related]

  • 4. [Effective treatment of peritoneal carcinosis by intraperitoneal cis-diamminedichloroplatinum (c-DDP) administration with systemic sodium thiosulfate protection. Clinical results and pharmacokinetics].
    Rückle H, Ehninger G, Jakob F, Wilms K.
    Klin Wochenschr; 1986 May 15; 64(10):467-74. PubMed ID: 3723994
    [Abstract] [Full Text] [Related]

  • 5. Clinical and pharmacokinetic study of intraperitoneal cisplatin at two dose levels: 100 mg/m2 alone or 200 mg/m2 with i.v. sodium thiosulfate.
    Canal P, de Forni M, Chatelut E, Chevreau C, Johnson NP, Houin G, Bugat R.
    Acta Med Austriaca; 1989 May 15; 16(3-4):84-6. PubMed ID: 2609919
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of sodium thiosulfate on cis-dichlorodiammineplatinum(II) toxicity and antitumor activity in L1210 leukemia.
    Howell SB, Taetle R.
    Cancer Treat Rep; 1980 May 15; 64(4-5):611-6. PubMed ID: 7191778
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Intraperitoneal versus intravenous infusion of cis-platinum in advanced ovarian cancer--examination of pharmacokinetics].
    Shindo K, Oikawa N, Atsumi Y, Chida S, Tuburaya T, Yajima A.
    Gan To Kagaku Ryoho; 1987 Mar 15; 14(3 Pt 1):639-44. PubMed ID: 3827260
    [Abstract] [Full Text] [Related]

  • 10. [Intraperitoneal administration of cis-diamminedichloroplatinum (II) for peritoneal carcinomatosis caused by gastric cancers].
    Kurihara N, Kumai K, Kubota T, Furukawa T, Yamamoto T, Shimada A, Shibata S, Saikawa Y, Ogawa S, Murayama Y.
    Gan To Kagaku Ryoho; 1993 Aug 15; 20(11):1645-8. PubMed ID: 8373238
    [Abstract] [Full Text] [Related]

  • 11. [Intraperitoneal and intrapleural two channel chemotherapy by cisplatinum (DDP) and sodium thiosulfate for the treatment of ovarian cancer].
    Hatae M, Tezuka H, Ushiki N, Ezono Y, Igyuin H, Terahara M, Hokanishi H.
    Gan To Kagaku Ryoho; 1984 Mar 15; 11(3):433-9. PubMed ID: 6538403
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Population pharmacokinetics of cisplatin in patients with advanced ovarian cancer during intraperitoneal hyperthermia chemotherapy.
    Panteix G, Beaujard A, Garbit F, Chaduiron-Faye C, Guillaumont M, Gilly F, Baltassat P, Bressolle F.
    Anticancer Res; 2002 Mar 15; 22(2B):1329-36. PubMed ID: 12168946
    [Abstract] [Full Text] [Related]

  • 14. Intraperitoneal cisplatin with systemic thiosulfate protection.
    Howell SB, Pfeifle CL, Wung WE, Olshen RA, Lucas WE, Yon JL, Green M.
    Ann Intern Med; 1982 Dec 15; 97(6):845-51. PubMed ID: 6890785
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Pharmacokinetic study of intraperitoneal chemotherapy with high-dose cisplatin for advanced ovarian cancer].
    Deng C, Huang R, Lian L.
    Zhonghua Fu Chan Ke Za Zhi; 1996 Mar 15; 31(3):159-62. PubMed ID: 8758790
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Reduced systemic drug exposure by combining intraarterial cis-diamminedichloroplatinum(II) with hemodialysis of regional venous drainage.
    Oldfield EH, Clark WC, Dedrick RL, Egorin MJ, Austin HA, DeVroom HD, Joyce KM, Doppman JL.
    Cancer Res; 1987 Apr 01; 47(7):1962-7. PubMed ID: 3815385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.